Updated Jul 16, 2026
HILZINGER KURT J has filed 2 SEC Form 4 filings across 2 companies in the last 90 days — buying. Lifetime open-market purchases: $177K.
Kurt J. Hilzinger is a corporate director known for his role at Outlook Therapeutics, Inc. and Humana Inc. He has been involved in the biopharmaceutical and healthcare sectors, contributing to the governance of these companies.
| Role | Director |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-27 | OTLK | Outlook Therapeutics, Inc. | P — Open-market purchase | 400.0K | $0.44 | $177K |
Kurt J. Hilzinger is a corporate director known for his role at Outlook Therapeutics, Inc. and Humana Inc. He has been involved in the biopharmaceutical and healthcare sectors, contributing to the governance of these companies.…
2 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 1 open-market purchases ($177K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live HILZINGER KURT J profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.